Molecular analysis of the AGXT gene in Italian patients with primary hyperoxaluria type 1 (PH1).
Specimens were collected from 22 Italian patients with primary hyperoxaluria type 1 (PH1). Ten of them had already been analyzed by molecular biology. To clarify the molecular characteristics of the AGXT gene disease responsible for PH1, DNA samples were examined for known mutations by hybridisation of PCR products with Sequence Specific Oligonucleotides (PCR-SSO). We planned to identify new mutations of the AGXT gene by heteroduplex analysis followed by direct sequencing. We had already standardized a) the conditions for the amplification of the 11 exons of AGXT, b) the PCR-SSO technique and c) the heteroduplex analysis of amplified products. Preliminary results demonstrated that the AGXT mutations described in previous studies were found only in 40% of the examined Italian patients with PH1. The remaining 60% of mutations should be characterised in future studies.
Ferrettini
C
C
Laboratorio Calcolosi Renale, Ospedale Mauriziano Umberto I, Torino, Italy.
Pirulli
D
D
Cosseddu
D
D
Marangella
M
M
Petrarulo
M
M
Mazzola
G
G
Vatta
S
S
Amoroso
A
A
D002648:Child; D004252:DNA Mutational Analysis; D005091:Exons / Q000235:genetics; D005260:Female; D006801:Humans; D006960:Hyperoxaluria, Primary / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics*; D007558:Italy / Q000453:epidemiology; D008297:Male; D009154:Mutation; D016133:Polymerase Chain Reaction; D000637:Transaminases / Q000172:deficiency / Q000235:genetics*
D000637:Transaminases; C019635:Alanine-glyoxylate transaminase